Financial reports
10-K
2023 FY
Annual report
5 Mar 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
26 Apr 23
10-K
2022 FY
Annual report
9 Mar 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
Current reports
8-K
Entry into a Material Definitive Agreement
2 Apr 24
8-K
Other Events
1 Apr 24
8-K
Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
5 Mar 24
8-K
Cost Associated with Exit or Disposal Activities
29 Feb 24
8-K
Results of Operations and Financial Condition
12 Feb 24
8-K
Gritstone bio Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
8 Nov 23
8-K
Entry into a Material Definitive Agreement
27 Sep 23
8-K
Other Events
15 Aug 23
8-K
Gritstone bio Reports Second Quarter 2023 Financial Results and Provides Corporate Updates
9 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
21 Jun 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
2 Apr 24
424B5
Prospectus supplement for primary offering
1 Apr 24
S-8
Registration of securities for employees
5 Mar 24
S-3
Shelf registration
22 Dec 23
S-8
Registration of securities for employees
9 Mar 23
424B3
Prospectus supplement
14 Dec 22
S-3
Shelf registration
22 Nov 22
D
$45.00 mm in equity / options / securities to be acquired, sold $45.00 mm, 6 investors
8 Nov 22
424B5
Prospectus supplement for primary offering
9 May 22
S-8
Registration of securities for employees
9 May 22
Proxies
DEFA14A
Additional proxy soliciting materials
26 Apr 23
DEF 14A
Definitive proxy
26 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 22
DEF 14A
Definitive proxy
28 Apr 22
DEFA14A
Additional proxy soliciting materials
23 Apr 21
DEF 14A
Definitive proxy
23 Apr 21
DEFA14A
Additional proxy soliciting materials
24 Apr 20
DEF 14A
Definitive proxy
24 Apr 20
DEFA14A
Additional proxy soliciting materials
26 Apr 19
DEF 14A
Definitive proxy
26 Apr 19
Other
EFFECT
Notice of effectiveness
2 Jan 24
CORRESP
Correspondence with SEC
27 Dec 23
UPLOAD
Letter from SEC
27 Dec 23
EFFECT
Notice of effectiveness
2 Dec 22
CORRESP
Correspondence with SEC
28 Nov 22
UPLOAD
Letter from SEC
28 Nov 22
EFFECT
Notice of effectiveness
6 May 22
CORRESP
Correspondence with SEC
3 May 22
CORRESP
Correspondence with SEC
21 Mar 22
CORRESP
Correspondence with SEC
16 Mar 22
Ownership
SC 13G/A
Redmile Group, LLC
14 Feb 24
SC 13G/A
Point72 Asset Management, L.P.
14 Feb 24
SC 13G/A
Frazier Life Sciences Public Fund, L.P.
13 Feb 24
SC 13G
MORGAN STANLEY
8 Feb 24
4
Matthew Hawryluk
5 Feb 24
4
Erin Jones
5 Feb 24
4
Vassiliki Economides
5 Feb 24
4
Karin Jooss
5 Feb 24
4
James Cho
5 Feb 24
4
Andrew R Allen
5 Feb 24